XML 81 R67.htm IDEA: XBRL DOCUMENT v3.22.0.1
Acquisitions - 2021, Acquisitions (Details)
€ in Millions, $ in Millions
12 Months Ended
Nov. 17, 2021
USD ($)
Nov. 17, 2021
EUR (€)
Aug. 24, 2021
USD ($)
Oct. 15, 2018
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Consideration Transferred:                
Total consideration transferred $ 14.4     $ 6.1 $ 4.5      
Allocation of Consideration Transferred:                
Goodwill         339.5 $ 320.4 $ 293.0 $ 275.7
BSI Nano                
Allocation of Consideration Transferred:                
Goodwill         238.9 228.0 208.5 203.7
BSI Life Science                
Allocation of Consideration Transferred:                
Goodwill         100.3 $ 92.1 $ 84.2 $ 72.0
SCI Instruments                
Consideration Transferred:                
Contingent consideration     $ 1.0          
SCI Instruments | BSI Nano                
Consideration Transferred:                
Cash paid         28.0      
Contingent consideration         1.0      
Working capital adjustment         (0.6)      
Total consideration transferred         28.4      
Allocation of Consideration Transferred:                
Inventories         1.0      
Goodwill         12.6      
Liabilities assumed         (0.3)      
Total consideration transferred         28.4      
SCI Instruments | BSI Nano | Technology                
Allocation of Consideration Transferred:                
Intangible assets         7.1      
SCI Instruments | BSI Nano | Customer relationships                
Allocation of Consideration Transferred:                
Intangible assets         6.4      
SCI Instruments | BSI Nano | Backlog                
Allocation of Consideration Transferred:                
Intangible assets         1.2      
SCI Instruments | BSI Nano | Trade name                
Allocation of Consideration Transferred:                
Intangible assets         0.4      
Molecubes NV                
Consideration Transferred:                
Contingent consideration 0.4              
Total consideration transferred $ 21.1 € 18.7            
Molecubes NV | BSI Life Science                
Consideration Transferred:                
Cash paid         21.1      
Contingent consideration         0.4      
Total consideration transferred         21.5      
Allocation of Consideration Transferred:                
Cash         1.1      
Accounts receivable         1.2      
Inventories         1.5      
Other current assets         0.3      
Property, plant and equipment         0.1      
Goodwill         14.1      
Deferred taxes         (1.6)      
Liabilities assumed         (1.6)      
Total consideration transferred         21.5      
Molecubes NV | BSI Life Science | Technology                
Allocation of Consideration Transferred:                
Intangible assets         3.4      
Molecubes NV | BSI Life Science | Customer relationships                
Allocation of Consideration Transferred:                
Intangible assets         2.4      
Molecubes NV | BSI Life Science | Backlog                
Allocation of Consideration Transferred:                
Intangible assets         0.1      
Molecubes NV | BSI Life Science | Trade name                
Allocation of Consideration Transferred:                
Intangible assets         $ 0.5